The Allergy Diagnostics and Therapeutics Market is thriving due to rising allergy prevalence and advancements in immunotherapy and diagnostics. Market growth is accelerated by technological ...

As temperatures drop, activities like shoveling snow can become dangerous, especially with people with certain health ...

Among the standout performers in Deutsche Bank’s analysis: ...

Corvus Pharmaceuticals, Inc. jumps 165% on Phase 1 soquelitinib atopic dermatitis data; learn key efficacy, funding, and ...

Adimab's latest partner program to receive approval is GSK's Exdensur (depemokimab), approved in the US for the treatment of severe asthma with an eosinophilic phenotype and in the UK and Japan for ...

There is a good reason for health insurers to occasionally require prior authorization for medical treatment. If a doctor ...

This Community Information message is being issued for smoke across the Otways, Geelong, Melbourne south-eastern suburbs, Mornington Peninsula, parts of Phillip Island and surrounds . * You will see ...

Announced new data demonstrating a unique mechanism of action supporting the best-in-class potential of rademikibart –– Recruitment ongoing for ...

Regeneron Pharmaceuticals, Inc. nears a key earnings report after a strong JPM Healthcare update. Click here to find out why ...

We get what we pay for. In the U.S., doctors are paid very different sums for different patients, even when providing the ...

A new EPIC report says data brokers, ad-tech surveillance, and ICE enforcement are among the factors leading to a “health privacy crisis” that is eroding trust and deterring people from seeking care.

Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to ...